Stem-cell gene therapy moves toward approval.
L
L
Thompson
D000243:Adenosine Deaminase / Q000172:deficiency; D015703:Antigens, CD / Q000032:analysis; D018952:Antigens, CD34; D001854:Bone Marrow Cells; D002469:Cell Separation; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006412:Hematopoietic Stem Cells; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000235:genetics; D009316:National Institutes of Health (U.S.); D014481:United States
D015703:Antigens, CD; D018952:Antigens, CD34; D000243:Adenosine Deaminase